Laser Treatments in Female Urinary Incontinence

  • Ivan FistonićEmail author
  • Nikola Fistonić


Noninvasive treatment is recommended as first line for female urinary incontinence (UI). However, surgical procedures are more likely to be implemented to cure UI but are associated with more adverse events. Less invasive operative mesh techniques are relatively effective, but not devoid of complications such as bleeding, bladder perforation, urethral injury, infection, and retention that may require mesh resection. In patients for whom the risks of anesthesia and surgery are too high, a minimally invasive approach is recommended, and further research is needed in terms of more compliant, less invasive, and low-cost methods for the treatment of stress UI and pelvic floor dysfunction.

Contemporary scientific and technological breakthroughs have led to better clinical outcomes with minimally invasive procedures with shorter recovery times and lower implicated costs. In this sense, recent evidence supports laser treatment as an effective and compliant intervention for stress UI. In spite of promising initial results, there is still a need for long-term consistent evidence analyzing laser efficacy and safety in the treatment of female UI.


Urinary incontinence Minimally invasive treatment Erbium YAG laser CO2 laser 



Body mass index


Collagen Remodeling Capacity




Female sexual function index


Genitourinary syndrome of menopause


International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form


Intrinsic sphincter deficiency


Incontinence Severity Index


Lower urinary tract symptoms


Mid-urethral sling


Overactive bladder


Overactive Bladder Symptoms Score Questionnaire


Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire


Pelvic organ prolapse


Quality of life


Residual thermal damage


Stress urinary incontinence


Urethral closure pressure


Urinary incontinence


Vaginal erbium laser


  1. 1.
    Blaivas JG, Purohit RS, Benedon MS, Mekel G, Stern M, Billah M, et al. Safety considerations for synthetic sling surgery. Nat Rev Urol. 2015;12:481–509.CrossRefGoogle Scholar
  2. 2.
    Lazarou G, Minis E, Grigorescu B. Outcomes of stress urinary incontinence in women undergoing TOT versus Burch colposuspension with abdominal sacrocolpopexy. Int Urogynecol J. 2019;30:245–50.CrossRefGoogle Scholar
  3. 3.
    Han L, Wang L, Wang Q, Li H, Zang H. Association between pelvic organ prolapse and stress urinary incontinence with collagen. Exp Ther Med. 2014;7:1337–41.CrossRefGoogle Scholar
  4. 4.
    Rechberger T, Postawski K, Jakowicki JA, et al. Role of fascial collagen in stress urinary incontinence. Am J Obstet Gynecol. 1998;179:1511–4.CrossRefGoogle Scholar
  5. 5.
    Tinelli A, Malvasi A, Rahimi S, Negro R, Vergara D, Martignago R, Pellegrino M, Cavallotti C. Age-related pelvic floor modifications and prolapse risk factors in postmenopausal women. Menopause. 2010;17:204–12.CrossRefGoogle Scholar
  6. 6.
    Bergsland J. Major innovations and trends in the medical device sector. Acta Inform Med. 2012;20:44–6.CrossRefGoogle Scholar
  7. 7.
    El-Domyati M, Abd-El-Raheem T, Medhat W, et al. Multiple fractional erbium: yttrium-aluminum-garnet laser sessions for upper facial rejuvenation: clinical and histological implications and expectations. J Cosmet Dermatol. 2014;13:30–7.CrossRefGoogle Scholar
  8. 8.
    Tadir Y, Gaspar A, Lev-Sagie A, et al. Light and energy based therapeutics for genitourinary syndrome of menopause: consensus and controversies. Lasers Surg Med. 2017;49:137–59.CrossRefGoogle Scholar
  9. 9.
    Lapii GA, Yakovleva AY, Neimark AI. Structural reorganization of the vaginal mucosa in stress urinary incontinence under conditions of Er:YAG laser treatment. Bull Exp Biol Med. 2017;162:510–4.CrossRefGoogle Scholar
  10. 10.
    Fistonić N, Fistonić I, Guštek ŠF, Turina ISB, Marton I, Vižintin Z, Kažič M, Hreljac I, Perhavec T, Lukač M. Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women-a pilot study. Lasers Med Sci. 2016;31:635–43.CrossRefGoogle Scholar
  11. 11.
    Gambacciani M, Palacios S. Laser therapy for the restoration of vaginal function. Maturitas. 2017;99:10–5.CrossRefGoogle Scholar
  12. 12.
    Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M, Candiani M, Leone Roberti Maggiore U. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014;17:363–9.CrossRefGoogle Scholar
  13. 13.
    Athanasiou S, Pitsouni E, Antonopoulou A, Zacharakis D, Salvatore S, Falaggas ME, et al. The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women. Climacteric. 2016;19:512–8.CrossRefGoogle Scholar
  14. 14.
    Fistonic N, Fistonic I, Lukanovic A, Findri Gustek S, Sorta Bilajac T, Franic D. First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study. Climacteric. 2015;18(Suppl 1):37–42.CrossRefGoogle Scholar
  15. 15.
    Klovning A, Avery K, Sandvik H, Hunskaar S. Comparison of two questionnaires for assessing the severity of urinary incontinence: the ICIQ-UI SF versus the incontinence severity index. Neurourol Urodyn. 2009;28:411–5.CrossRefGoogle Scholar
  16. 16.
    Ogrinc BU, Sencar S, Lenasi H. Novel minimally invasive laser treatment of urinary incontinence in women. Lasers Surg Med. 2015;47:689–97.CrossRefGoogle Scholar
  17. 17.
    Tien YW, Hsiao SM, Lee CN, Lin HH. Effects of laser procedure for female urodynamic stress incontinence on pad weight, urodynamics, and sexual function. Int Urogynecol J. 2017;28:469–76.CrossRefGoogle Scholar
  18. 18.
    Gambacciani M, Levancini M, Russo E, Vacca L, Simoncini T, Cervigni M. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric. 2018;21:148–52.CrossRefGoogle Scholar
  19. 19.
    Pardo J, Sola V, Morales A. Treatment of female stress urinary incontinence with erbium YAG laser in non-ablative mode. Eur J Obstet Gynecol Reprod Biol. 2016;204:1–4.CrossRefGoogle Scholar
  20. 20.
    Leshunov EV, Martov AG. Application of laser technologies for treatment of urinary stress incontinence in women of reproductive age. Urologiia. 2015;1:36–40.Google Scholar
  21. 21.
    Neimark AI, Yakovleva AY, Lapii GA. Outcomes of ER:YAG laser treatment of stress urinary incontinence in women. Urologiia. 2018;2:20–5.CrossRefGoogle Scholar
  22. 22.
    Blaganje M, Šćepanović D, Žgur L, Verdenik I, Pajk F, Lukanović A. Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2018;224:153–8.CrossRefGoogle Scholar
  23. 23.
    Isaza PG, Jaguszewska K, Cardona JL, Lukaszuk M. Long-term effect of thermoablative fractional CO2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause. Int Urogynecol J. 2018;29:211–5.CrossRefGoogle Scholar
  24. 24.
    Pitsouni E, Grigoriadis T, Tsiveleka A, et al. Microablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: an observational study. Maturitas. 2016;94:131–6.CrossRefGoogle Scholar
  25. 25.
    Golubnitschaja O, Kinkorova J, Costigliola V. Predictive, preventive and personalised medicine as the hardcore of “horizon 2020”: EPMA position paper. EPMA J. 2014;5:6.CrossRefGoogle Scholar
  26. 26.
    Fistonić I, Fistonić N. Baseline ICIQ-UI score, body mass index, age, average birth weight, and perineometry duration as promising predictors of the short-term efficacy of Er:YAG laser treatment in stress urinary incontinent women: a prospective cohort study. Lasers Surg Med. 2018;50:636–43.CrossRefGoogle Scholar
  27. 27.
    Lane TM, Shah PJR. Valsalva leak point pressure in the evaluation of stress urinary incontinence. Braz J Urol. 2000;26:420–5.Google Scholar
  28. 28.
    McGuire EJ, Fitzpatrick CC, Wan J, et al. Clinical assessment of urethral sphincter function. J Urol. 1993;150:1452–4.CrossRefGoogle Scholar
  29. 29.
    Gaspar A, Brandi H. Non-ablative erbium YAG laser for the treatment of type III stress urinary incontinence (intrinsic sphincter deficiency). Lasers Med Sci. 2017;32:685–91.CrossRefGoogle Scholar
  30. 30.
    Gaspar A, Maestri S, Silva J, Brandi H, Luque D, Koron N, Vižintin Z. Intraurethral erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: a pilot study. Lasers Surg Med. 2018;50:802–7.CrossRefGoogle Scholar
  31. 31.
    Patel F. The effects of RF excited fractional CO2 laser on the vaginal canal in treating stress urinary incontinence [2G]. Obstet Gynecol. 2017;129:S71–2.CrossRefGoogle Scholar
  32. 32.
    Perino A, Cucinella G, Gugliotta G, Saitta S, Polito S, Adile B, Marci R, Calagna G. Is vaginal fractional CO2 laser treatment effective in improving overactive bladder symptoms in post-menopausal patients? Preliminary results. Eur Rev Med Pharmacol Sci. 2016;20:2491–7.PubMedGoogle Scholar
  33. 33.
    Zyczynski HM, Albo ME, Goldman HB, et al. Change in overactive bladder symptoms after surgery for stress urinary incontinence in women. Obstet Gynecol. 2015;126:423–30.CrossRefGoogle Scholar
  34. 34.
    Geirsson G, Fall M. Reflex interaction between the proximal urethra and the bladder. A clinical experimental study. Scand J Urol Nephrol. 1999;33:24–6.PubMedGoogle Scholar
  35. 35.
    Lin YH, Hsieh WC, Huang L, Liang CC. Effect of non-ablative laser treatment on overactive bladder symptoms, urinary incontinence and sexual function in women with urodynamic stress incontinence. Taiwan J Obstet Gynecol. 2017;56:815–20.CrossRefGoogle Scholar
  36. 36.
    Zerbinati N, Serati M, Origoni M, Candiani M, Iannitti T, Salvatore S. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci. 2015;30:429–36.CrossRefGoogle Scholar
  37. 37.
    Samuels JB, Garcia MA. Treatment to external labia and vaginal canal with CO2 laser for symptoms of vulvovaginal atrophy in postmenopausal women. Aesthet Surg J. 2019;39:83–93.CrossRefGoogle Scholar
  38. 38.
    Lapii GA, Yakovleva AY, Neimark AI, Lushnikova EL. Study of proliferative activity of vaginal epithelium in women with stress urinary incontinence treated by Er:YAG laser. Bull Exp Biol Med. 2017;163:280–3.CrossRefGoogle Scholar
  39. 39.
    Price CR, Carniol PJ, Glaser DA. Skin resurfacing with the erbium:YAG laser. Facial Plast Surg Clin North Am. 2001;9:291–302.PubMedGoogle Scholar
  40. 40.
    Newman JB, Lord JL, Ash K, McDaniel DH. Variable pulse erbium:YAG laser skin resurfacing of perioral rhytides and side-by-side comparison with carbon dioxide laser. Lasers Surg Med. 2000;26:208–14.CrossRefGoogle Scholar
  41. 41.
    Lee MS. Treatment of vaginal relaxation syndrome with an erbium:YAG laser using 90° and 360° scanning scopes: a pilot study & short-term results. Laser Ther. 2014;23:129–38.CrossRefGoogle Scholar
  42. 42.
    Lukac M, Gaspar A, Bajd F. Dual tissue remodeling: non-ablative resurfacing of soft tissues with FotonaSmooth® mode Er:YAG laser. J Laser Health Acad. 2018;1:1–16.Google Scholar
  43. 43.
    Hutchinson-Colas J, Segal S. Genitourinary syndrome of menopause and the use of laser therapy. Maturitas. 2015;82:342–5.CrossRefGoogle Scholar
  44. 44.
    Helbig D, Bondendorf MO, Grunewald S, et al. Immunohistochemical investigation of wound healing in response to fractional photothermolysis. J Biomed Opt. 2009;14:064044.CrossRefGoogle Scholar
  45. 45.
    Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, Khan SA. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016;215:704–11.CrossRefGoogle Scholar
  46. 46.
    Song S, Budden A, Short A, Nesbitt-Hawes E, Deans R, Abbott J. The evidence for laser treatments to the vulvo-vagina: making sure we do not repeat past mistakes. Aust N Z J Obstet Gynaecol. 2018;58:148–62.CrossRefGoogle Scholar
  47. 47.
    Arunkalaivanan A, Kaur H, Onuma O. Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence. Int Urogynecol J. 2017;28:681–5.CrossRefGoogle Scholar
  48. 48.
    Digesu G, Swift S. Laser treatment in urogynaecology and the myth of the scientific evidence. Int Urogynecol J. 2017;28:1443–4.CrossRefGoogle Scholar
  49. 49.
    Pitsouni E, Grigoriadis T, Falagas ME, Salvatore S, Athanasiou S. Laser therapy for the genitourinary syndrome of menopause. A systematic review and meta-analysis. Maturitas. 2017;103:78–88.CrossRefGoogle Scholar
  50. 50.
    Faubion SS, Sood R, Kapoor E. Genitourinary syndrome of menopause: management strategies for the clinician. Mayo Clin Proc. 2017;92:1842–9.CrossRefGoogle Scholar
  51. 51.
    Conté C, Jauffret T, Vieillefosse S, Hermieu JF, Deffieux X. Laser procedure for female urinary stress incontinence: a review of the literature. Prog Urol. 2017;27:1076–83.CrossRefGoogle Scholar
  52. 52.
    Walter JE, Larochelle A. No. 358-intravaginal laser for genitourinary syndrome of menopause and stress urinary incontinence. J Obstet Gynaecol Can. 2018;40:503–11.CrossRefGoogle Scholar
  53. 53.
    Shamout S, Campeau L. Stress urinary incontinence in women: current and emerging therapeutic options. Can Urol Assoc J. 2017;11(6 Suppl 2):S155–8.CrossRefGoogle Scholar
  54. 54.
    Henriques J, Brandão P, Almeida A, et al. Female urinary incontinence: is laser treatment effective? A systematic review. Obstet Gynecol Int J. 2018;9:227–32.Google Scholar
  55. 55.
    Sinderman AD, D’Agostino RB Sr, Pencina MJ. The role of physicians in the era of predictive analytics. JAMA. 2015;314:25–6.CrossRefGoogle Scholar
  56. 56.
    Vogenberg FR. Predictive and prognostic models: implications for healthcare decision-making in a modern recession. Am Health Drug Benefits. 2009;2:218–22.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Institute for Women’s HealthZagrebCroatia
  2. 2.Ob/Gyn DepartmentUniversity Hospital MerkurZagrebCroatia

Personalised recommendations